Dashboard
Financial statements
MET

Company financials

MetLife

Financials Life & Health Insurance New York City, New York Last filing Feb 19, 2026 · FY2025
Revenue FY2025
$77.1B
3y CAGR +3.9% P12
Net income FY2025
$3.4B
Net margin +4.4% P4
Total assets FY2025
$745.2B
ROA +0.5% P5
Operating cash flow FY2025
$17.1B
20 yrs · FY2006–FY2025 9 filed · 0 derived · 0 blank

Year-over-year change per cell; first column has no prior.

Balance Sheet

Assets, liabilities, and equity

27 accounts · 1 year
Total assets $745.2B
Total liabilities $716.2B
Shareholders equity $28.4B
Account 2025 Trend
Assets
Cash and Cash Equivalents
Short Term Investments
Accounts Receivable
Other Current Assets
Property,Plant and Equipment
Goodwill
Intangible Assets
Long Term Investments
Deferred Tax Assets
Other Noncurrent Assets
Total Assets
Liabilities
Current Portion of Long Term Debt
Other Current Liabilities
Total Current Liabilities
Long Term Debt
Deferred Tax Liabilities
Other Noncurrent Liabilities
Total Liabilities
Equity
Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings
Treasury Stock
Accumulated Other Comprehensive Income
Noncontrolling Interest
Total Stockholders Equity
Total Liabilitiesand Equity

Key Ratios

Margins, returns, liquidity, leverage, efficiency

Computed at import · 1 year
Ratio 2025
Profitability
Gross margin
Operating margin +8.0%
Net margin +4.4%
FCF margin
Growth
Revenue CAGR (3y) +3.9%
Returns
ROE +11.9%
ROA +0.5%
ROIC +63.3%
Liquidity
Current ratio
Quick ratio 0.03x
Leverage
D/E 25.22x
Interest coverage 8.48x
Efficiency
Asset turnover 0.10x
Cash conversion cycle

Valuation

Price against fundamentals

FY2025 fundamentals · no price

No price data cached, so there is nothing to multiply. Load prices from the Stock Data tab and this panel reprices itself.

Notes

Your annotations

Not watched
Saving notes adds MET to your watchlist.